Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment

Melanoma is the most lethal form of skin cancer and surgery remains the preferred and most effective treatment. Nevertheless, there are cases where surgery is not a viable method and alternative treatments are therefore adopted. One such treatment that has been tested is topical 5% imiquimod (IMQ) c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tambunlertchai, Supreeda, Geary, Sean M., Salem, Aliasger K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611754/
https://www.ncbi.nlm.nih.gov/pubmed/36297510
http://dx.doi.org/10.3390/pharmaceutics14102076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611754/
https://www.ncbi.nlm.nih.gov/pubmed/36297510
http://dx.doi.org/10.3390/pharmaceutics14102076

Ejemplares similares